Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.21 by 90.48 percent. This is a 471.43 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $225.607 million which beat the analyst consensus estimate of $172.700 million by 30.64 percent. This is a 78.13 percent increase over sales of $126.656 million the same period last year.